title: Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions.
abstract: CD40-CD154-mediated signaling has recently been described as playing a role in cellular functions involved in atherosclerotic processes. CD40 is expressed in macrophages, lymphocytes, endothelial cells, and vascular smooth muscle cells. However, cross-sectional studies investigating the expression of CD40 in atherosclerotic lesions are lacking. In the present study the expression of CD40 was studied in atherosclerotic lesions from 43 patients classified according to the World Health Organization criteria. Serial immunohistologic stainings of human iliac arteries from 43 patients were performed using monoclonal antibodies. Lesions were classified according to World Health Organization criteria, and CD40 expression was analyzed with regard to cell morphology and cellular markers by 2 independent observers. Human atherosclerotic lesions revealed a significant increase in intimal thickness, number of inflammatory infiltrates, and CD40-positive macrophages and vascular smooth muscle cells with progression of the lesions. This increase was most prominent from stage 0 to stage I. A significant correlation between intimal thickness and CD40-positive macrophages (r = 0.75, p <0.0005) and CD40-positive vascular smooth muscle cells (r = 0.81, p <0.0005) was observed. Ligation of the cellular CD40 receptor contributes to inflammatory cellular events in human vascular smooth muscle cells. These data suggest a direct association of CD40 expression in atherosclerotic lesions with early plaque development.
authors.affiliation: Department of Medicine/Cardiology, Virchow Klinikum Humboldt Universität Berlin, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Bruemmer
authors.forename: U
authors.initials: U
authors.lastname: Riggers
authors.forename: J
authors.initials: J
authors.lastname: Holzmeister
authors.forename: M
authors.initials: M
authors.lastname: Grill
authors.forename: F
authors.initials: F
authors.lastname: Lippek
authors.forename: U
authors.initials: U
authors.lastname: Settmacher
authors.forename: V
authors.initials: V
authors.lastname: Regitz-Zagrosek
authors.forename: E
authors.initials: E
authors.lastname: Fleck
authors.forename: K
authors.initials: K
authors.lastname: Graf
mesh_terms: D000368:Aged; D001161:Arteriosclerosis / Q000276:immunology* / Q000473:pathology*; D019013:CD40 Antigens / Q000378:metabolism*; D023201:CD40 Ligand / Q000378:metabolism; D003430:Cross-Sectional Studies; D018450:Disease Progression; D005260:Female; D006801:Humans; D007083:Iliac Artery / Q000276:immunology; D007150:Immunohistochemistry; D008264:Macrophages / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009131:Muscle, Smooth, Vascular / Q000276:immunology*; D015398:Signal Transduction
chemical_list: D019013:CD40 Antigens; D023201:CD40 Ligand